STAT

DECEMBER 3, 2023

LONDON — The booming obesity market is attracting another player, as pharma giant Roche said Monday it was acquiring Carmot Therapeutics and the company’s line of weight loss drug candidates for $2.7 billion upfront.   The deal for Carmot, which is based in Berkeley, Calif., includes additional milestone payments of up to $400 million.

140

140

Fierce Pharma

DECEMBER 3, 2023

As AbbVie, Johnson & Johnson, AstraZeneca and BeiGene are battling it out in the same BTK inhibitor market, Eli Lilly is trailblazing a new path for the blood cancer drug class. | As AbbVie and Johnson & Johnson, AstraZeneca and BeiGene are battling it out in the same BTK inhibitor market, Eli Lilly is trailblazing a new path for the blood cancer drug class with an accelerated approval in post BTK/BCL-2 chronic lymphocytic leukemia.

FDA 121

FDA 121

Med Ed 101

DECEMBER 3, 2023

Many institutions that pass medications need to be aware of when medications expire. The GLP-1 agonist class has been quickly expanding so we wanted to put together a storage chart to ensure that healthcare professionals and patients properly store their medications. In addition to the visual GLP-1 Agonist storage chart on this page, I’ve included […] The post GLP-1 Agonist Storage Chart – Free PDF appeared first on Med Ed 101.

104

104

The Guardian - Pharmaceutical Industry

DECEMBER 3, 2023

Royal portraits | Viagra article | Losing sucks | Karlheinz Stockhausen | Hum improvement | Appalling apostrophes I’m confused. Is the £8m that Polly Toynbee reports is being spent by the government to send an “oak-framed portrait of the king” to every school going to encourage pupils to attend or have the reverse effect ( Too many pupils miss lessons, says Ofsted, and that’s right.

47

47

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

The FDA Law Blog

DECEMBER 3, 2023

By Faraz Siddiqui & Alan M. Kirschenbaum — The Inflation Reduction Act (IRA) significantly changed the Part D benefit. As part of this change, the Coverage Gap Discount Program (CGDP), a program that has existed since 2011, will sunset on December 31, 2024, and be replaced by the Medicare Part D Manufacturer Discount Program (the “Discount Program”).

Labelling 105

Labelling Compounding Payment Processing Vaccines 105